Literature DB >> 18956234

Spectrofluorimetric determination of famotidine in pharmaceutical preparations and biological fluids. Application to stability studies.

M I Walash1, A el-Brashy, N el-Enany, M E Kamel.   

Abstract

A simple, economic, selective, and stability indicating spectrofluorimetric method was developed for the determination of famotidine (FMT); is based on its reaction with 9, 10-phenanthraquinone in alkaline medium to give a highly fluorescent derivative measured at 560 nm after excitation at 283 nm. The fluorescence intensity-concentration plot was rectilinear over the concentration range of 50-600 ng/ml with minimum quantification limit (LOQ) of 13.0 ng/ml and minimum detection limit (LOD) of 4.3 ng/ml. The factors affecting the development of the fluorescence intensity of the reaction product were carefully studied and optimized. The method was applied for the determination of FMT in its dosage forms. The stability of the compound was studied, and the proposed method was found to be stability indicating one. The results obtained were in good agreement with those obtained by the official method. Furthermore, the method was applied for the determination of FMT in spiked and real human plasma. The mean % recovery (n = 4) was found to be 99.94 +/- 0.24, and 105.13 +/- 0.64 for spiked and real human plasma, respectively. The composition of the reaction product as well as its stability constant was also investigated. Moreover, the method was utilized to investigate the kinetics of both alkaline and oxidative induced degradation of the drug. The apparent first order rate constant and half life time of the degradation product was calculated. A proposal of the reaction pathway was postulated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18956234     DOI: 10.1007/s10895-008-0421-3

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  16 in total

1.  Improved selectivity in detection of polar basic drugs by liquid chromatography-electrospray ionization mass spectrometry. Illustration using an assay method for the determination of famotidine in human plasma.

Authors:  M A Campanero; I Bueno; M A Arangoa; M Escolar; E G Quetglás; A López-Ocáriz; J R Azanza
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-11-05

2.  Fluorescence quenching high-performance thin-layer chromatographic analysis utilizing a scientifically operated charge-coupled device detector.

Authors:  R E Simon; L K Walton; Y Liang; M B Denton
Journal:  Analyst       Date:  2001-04       Impact factor: 4.616

3.  Spectrophotometric determination of three anti-ulcer drugs through charge-transfer complexation.

Authors:  Sheikha Al-Ghannam; Fathalla Belal
Journal:  J AOAC Int       Date:  2002 Sep-Oct       Impact factor: 1.913

4.  Application of ninhydrin to spectrophotometric determination of famotidine in drug formulations.

Authors:  Nafisur Rahman; Mohammad Kashif
Journal:  Farmaco       Date:  2003-10

5.  Development of a rapid HPLC method for determination of famotidine in human plasma using a monolithic column.

Authors:  A Zarghi; A Shafaati; S M Foroutan; A Khoddam
Journal:  J Pharm Biomed Anal       Date:  2005-09-15       Impact factor: 3.935

6.  Spectrofluorimetric determination of guanethidine sulphate, guanoxan sulphate and amiloride hydrochloride in tablets and in biological fluids using 9,10-phenanthraquinone.

Authors:  M H Abdel-Hay; S M Galal; M M Bedair; A A Gazy; A A Wahbi
Journal:  Talanta       Date:  1992-10       Impact factor: 6.057

7.  Determination of famotidine in low-volume human plasma by normal-phase liquid chromatography/tandem mass spectrometry.

Authors:  L Zhong; R Eisenhandler; K C Yeh
Journal:  J Mass Spectrom       Date:  2001-07       Impact factor: 1.982

8.  A study on the nickel II-famotidine complexes.

Authors:  Malgorzata Barańska; Elzbieta Gumienna-Kontecka; Henryk Kozlowski; Leonard M Proniewicz
Journal:  J Inorg Biochem       Date:  2002-11-11       Impact factor: 4.155

9.  New colorimetric methods for the determination of trazodone HCl, famotidine, and diltiazem HCl in their pharmaceutical dosage forms.

Authors:  Magda M Ayad; Abdalla Shalaby; Hisham E Abdellatef; Mervat M Hosny
Journal:  Anal Bioanal Chem       Date:  2003-05-16       Impact factor: 4.142

10.  Stability indicating method for famotidine in pharmaceuticals using porous graphitic carbon column.

Authors:  Nawel Helali; Lotfi Monser
Journal:  J Sep Sci       Date:  2008-02       Impact factor: 3.645

View more
  2 in total

1.  Application of sulfur and nitrogen doped carbon quantum dots as sensitive fluorescent nanosensors for the determination of saxagliptin and gliclazide.

Authors:  Galal Magdy; Amira A Al-Enna; Fathalla Belal; Ramadan A El-Domany; Ahmed M Abdel-Megied
Journal:  R Soc Open Sci       Date:  2022-06-01       Impact factor: 3.653

2.  Utility of N-bromosuccinimide for the titrimetric and spectrophotometric determination of famotidine in pharmaceutical formulations.

Authors:  O Zenita; K Basavaiah
Journal:  Int J Anal Chem       Date:  2011-06-12       Impact factor: 1.885

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.